CN101961466B - Snake venom capsule for treating cancer - Google Patents
Snake venom capsule for treating cancer Download PDFInfo
- Publication number
- CN101961466B CN101961466B CN2010105054122A CN201010505412A CN101961466B CN 101961466 B CN101961466 B CN 101961466B CN 2010105054122 A CN2010105054122 A CN 2010105054122A CN 201010505412 A CN201010505412 A CN 201010505412A CN 101961466 B CN101961466 B CN 101961466B
- Authority
- CN
- China
- Prior art keywords
- venom
- powder
- agkistrodon
- radix
- snake
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003998 snake venom Substances 0.000 title claims abstract description 24
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 23
- 201000011510 cancer Diseases 0.000 title claims abstract description 23
- 239000002775 capsule Substances 0.000 title claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 36
- 239000002435 venom Substances 0.000 claims abstract description 16
- 210000001048 venom Anatomy 0.000 claims abstract description 16
- 231100000611 venom Toxicity 0.000 claims abstract description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 9
- 239000002642 cobra venom Substances 0.000 claims abstract description 9
- 235000008434 ginseng Nutrition 0.000 claims abstract description 9
- 241001505404 Deinagkistrodon acutus Species 0.000 claims abstract description 8
- 241000222336 Ganoderma Species 0.000 claims abstract description 8
- 241000272108 Ophiophagus hannah Species 0.000 claims abstract description 7
- 241000270295 Serpentes Species 0.000 claims abstract description 7
- 241000271039 Agkistrodon Species 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 14
- 241001474977 Palla Species 0.000 claims description 9
- 241000208340 Araliaceae Species 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 7
- 241000269417 Bufo Species 0.000 claims description 6
- 241000271042 Gloydius halys Species 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 231100000614 poison Toxicity 0.000 claims description 4
- 239000002574 poison Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 10
- 210000004027 cell Anatomy 0.000 abstract description 8
- 230000004089 microcirculation Effects 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 210000000170 cell membrane Anatomy 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 241000987738 Gloydius blomhoffii Species 0.000 abstract 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 2
- 230000003902 lesion Effects 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 240000006432 Carica papaya Species 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241000746716 Typhonium Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 238000001035 drying Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000009636 Huang Qi Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 241000722823 Armadillidium Species 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 241001530038 Pantherophis obsoletus Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000271897 Viperidae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 201000004637 gastric cardia carcinoma Diseases 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002476 tumorcidal effect Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a snake venom capsule for treating cancer, which is prepared from the following materials: agkistrodon blomhoffii ussurensis in northern China, agkistrodon blomhoffii suspectum in the middle and lower reaches of the Yangtze River in China, agkitrodon acutus venom, cobra venom, king cobra venom, bungarotoxin and traditional Chinese medicines of toad coat, dried toad skin, ganoderma spore, pueraria lobata powder, coix seed, giant typhonium rhizome, common threewingnut root, papaya, pseudoginseng root, ginseng, glossy privet fruit, Chinese angelica, agkistrodon acutus powder and cobra powder according to a ratio of 1:5. The snake venom capsule solves the problem of single curative effect or low treatment effect in the prior art, directly destroys cell membranes of cancer cells so as to fulfill the aim of killing the cancer cells, blocks nutrition supply of cancer tissues so as to fulfill the aim of destroying cancer cells, promotes and improves microcirculation of lesion tissues, timely recovers normal function of the lesion tissues, and has the characteristics of good curative effect and wide application range.
Description
One, technical field
The present invention relates to a kind of compositions for the treatment of cancer, be specifically related to a kind of Snake Venom Capsule for the treatment of cancer.
Two, background technology
Human body produces cancerous tissue former thereby formation because of bad life habits, stress, environmental pollution etc.From microcosmic, above factor has been facilitated the sudden change of human body gene, causes canceration.On macroscopic view, above undesirable element has destroyed the normal operation of human endocrine, cause the endocrine disturbance, microcirculation is obstructed, form sour environment in the body, the noxious substance that produces in the body can not be in time, excrete swimmingly, forms carbuncle in certain organ in vivo and stop, through the progressively accumulation of long period, form tumor.
Chinese patent CN1426800 discloses a kind of Snake Venom Capsule prescription for the treatment of pulmonary carcinoma and preparation method thereof.Snake Venom Capsule is by agkistrodon halyx pallas venom, agkistrodon acutus venom, cobra venom, pallas pit viper powder, Ophidia black snake powder, Ganoderma, Fructus Psoraleae, Radix Ginseng, Radix Codonopsis, Armadillidium, Polyporus, Rhizoma Curcumae, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Rhizoma Chuanxiong, Radix Et Rhizoma Rhei, Semen Coicis, Radix Notoginseng etc. tens flavor Chinese herbal medicine are formulated through decoction, filtration, grinding, mixing, stirring, screen, operation such as encapsulated according to a certain ratio.Medicine source abundance, method for making is easy, and is economical and practical, and finished product adopts capsule dress system, takes simply, is used for patient's treatment, and safety, reliable, convenient, evident in efficacy, without any side effects is the desirable medicine of treatment pulmonary carcinoma.
Chinese patent CN101104011 discloses a kind of medicine for the treatment of malignant tumor, and the raw materials of effective components weight portion is: agkistrodon halyx pallas venom powder 1-10, Radix Ginseng 30-100, Radix Astragali extractum 50-100, Margarita layer powder 10-30.The scalable body system, existing analgesia, the effect of dwindling lump, improving immunologic function have QI invigorating again, calm the nerves, relieving convulsion, stimulating appetite, the effect in prolongation patient life-span; And preparation technology is simple and reliable, taking convenience, and curative effect is obvious, and the medicine source is abundant, is a kind of three bonded novel pure Chinese medicinal preparations of preventing, control, support.
Above-mentioned two patent drugs all are aided with other Chinese medicine with snake venom to be made, because snake venom content is few, so curative effect is single or therapeutic effect is not good.
Three, summary of the invention
Technical problem to be solved by this invention provides a kind of Snake Venom Capsule for the treatment of cancer, its good effect, applied widely.
For solving the problems of the technologies described above, the present invention treats the Snake Venom Capsule of cancer, by weight, and snake venom: Chinese medicine=1: 5;
The parts by weight of described snake venom are:
China northern agkistrodon halys ussuriensis poison 1.5-2.5, basin, the Chinese middle and lower reach of Yangtze River blunt tail agkistrodon halyx pallas venom 1.5-2.5, agkistrodon acutus venom 4-6, cobra venom 2-4, Ophiophagus hannah (Cantor). 1.5-2.5, bungarotoxin 0.5-1.5;
The parts by weight of described Chinese medicine are:
Toad is sloughed off 0.5-1.5, Bufo siccus dried bark 3-5, Ganoderma spore powder 8-12, powder of Radix Puerariae 12-18, Semen Coicis 3-7, Rhizoma Typhonii 3-7, Radix Tripterygii Wilfordii 3-7, Fructus Chaenomelis 3-7, Radix Notoginseng 3-7, Radix Ginseng 3-7, Fructus Ligustri Lucidi 3-7, Radix Angelicae Sinensis 3-7, Agkistrodon powder 10-20, glasses snake powder 8-22.
The cell membrane of the contained direct dissolved cancer cell of protease in the snake venom reaches the purpose of kill cancer cell.
Contained coagulant element is blocked the spontaneous cover microcirculqtory system of cancerous tissue in the snake venom, makes cancerous tissue not obtain nutrition from human body, reaches the purpose of destroying cancerous tissue.
Contained anticoagulant element is directly got through the microcirculqtory system because of the normal structure of cancerous tissue blocking-up in the snake venom, makes cancerous tissue normal structure on every side can obtain nutrition, reaches the normal function that guarantees cancerous tissue place organ.
Cancerous cell is grown in weak acid environment, is suppressed to generate in weakly alkaline environment.Because of human body in pollution, stress and bad life habits, formed intravital weak acid environment for a long time, for the generation of cancerous cell provides soil.Snake venom becomes a lot of micromolecule polypeptides through the zymolysis of digestion by high molecular weight protein, is the alkalescence material, after absorption of human body, has weakly acidic cancerous tissue with regard to directly running quickly and goes, and kills cancerous tissue, forms targeted therapy.
Snake venom has played the normal microcirculation of mediation in treatment cancer process, block improper microcirculatory effect, is aided with traditional Chinese medicine medicine for preventing again, reaches the purpose of intensive treatment.Cancer is body void often, helps with suitable conditioning Chinese medicine again, reaches the purpose of setting upright.
The direct tumoricidal cell membrane of snake venom reaches the purpose of kill cancer cell.The nutrition supply of blocking-up cancerous tissue reaches the purpose of destroying cancerous tissue.Activating blood circulation to dissipate blood stasis, mass dissipating and swelling eliminating promotes and the microcirculation that improves pathological tissues, in time recovers the normal function of pathological tissues.
Grind into above powder of 120 orders and snake venom after the equal intensive drying of above Chinese medicine and puddle evenly, fill becomes the 0.3g/ capsules to get finished product.Oral 9 of cancer patient every day, three times on the one each three.
The present invention is forbidden under the situation of the drop-down blood of spitting blood on the cancer patient without exception.
Rectal cancer, colon cancer or carcinoma of gastric cardia patient, performing an operation through hospital has connect artificial organ, without exception forbidding.
The careful usefulness of leukaemic.Patient for oozing of blood in the body is forbidden without exception.
All all kinds of cancer patients on probation all are through after hospital's specialty treatment, can't continue treatment again, only are judged to be less than the trimestral vital stage through the attending doctor, leave hospital and go home to prepare the patient of funeral affairs.Behind trial edition invention Snake Venom Capsule, to now, none example was dead from 2005 first examples.
Principle on probation: patient's life span is in three months, and the patient was the treatment phase with 1 year, and every three months is a course of treatment.The vital stage more than two times of last the natural duration of life that all breakthrough medical science is judged is qualified.
Cancer of pancreas 12 examples, effective percentage 〉=95%;
Hepatocarcinoma 30 examples, effective percentage 〉=95%;
Osteocarcinoma 22 examples, effective percentage 〉=95%;
Pulmonary carcinoma 37 examples, effective percentage 〉=95%;
Lymphatic cancer 6 examples, effective percentage 〉=95%;
The brain cancer 7 examples, effective percentage 〉=95%;
Other special diseases, can list the treatment of cancer ranks in:
Femur necrosis 120 examples, effective percentage 〉=98%;
Uremia's 12 examples, effective percentage 〉=95%;
Lupus erythematosus 4 examples, effective percentage 〉=95%;
Many complication 25 examples of advanced diabetes, effective percentage 〉=90%.
Four, the specific embodiment
Embodiment 1
With the toad after the intensive drying slough off 0.5kg, Bufo siccus dried bark 5kg, Ganoderma spore powder 8.5kg, powder of Radix Puerariae 15kg, Semen Coicis 3kg, Rhizoma Typhonii 3kg, Radix Tripterygii Wilfordii 3kg, Fructus Chaenomelis 3kg, Radix Notoginseng 3kg, Radix Ginseng 3kg, Fructus Ligustri Lucidi 3kg, Radix Angelicae Sinensis 3kg, Agkistrodon powder 10kg, glasses snake powder 22kg grind into the above powder of 120 orders, puddle evenly with the northern agkistrodon halys ussuriensis of China malicious 1.5kg, basin, the Chinese middle and lower reach of Yangtze River blunt tail agkistrodon halyx pallas venom 1.5kg, agkistrodon acutus venom 6kg, cobra venom 4kg, Ophiophagus hannah (Cantor). 2.5kg, bungarotoxin 1.5kg, fill becomes the 0.3g/ capsules to get finished product.
Embodiment 2
With the toad after the intensive drying slough off 1kg, Bufo siccus dried bark 3kg, Ganoderma spore powder 12kg, powder of Radix Puerariae 12kg, Semen Coicis 4kg, Rhizoma Typhonii 4kg, Radix Tripterygii Wilfordii 4kg, Fructus Chaenomelis 3kg, Radix Notoginseng 3kg, Radix Ginseng 4kg, Fructus Ligustri Lucidi 4kg, Radix Angelicae Sinensis 3kg, Agkistrodon powder 20kg, glasses snake powder 8kg grind into the above powder of 120 orders, puddle evenly with the northern agkistrodon halys ussuriensis of China malicious 2.5kg, basin, the Chinese middle and lower reach of Yangtze River blunt tail agkistrodon halyx pallas venom 2.5kg, agkistrodon acutus venom 6kg, cobra venom 3kg, Ophiophagus hannah (Cantor). 1.5kg, bungarotoxin 1.5kg, fill becomes the 0.3g/ capsules to get finished product.
Embodiment 3
With the toad after the intensive drying slough off 1.5kg, Bufo siccus dried bark 4kg, Ganoderma spore powder 8kg, powder of Radix Puerariae 18kg, Semen Coicis 5.5kg, Rhizoma Typhonii 5kg, Radix Tripterygii Wilfordii 5kg, Fructus Chaenomelis 5kg, Radix Notoginseng 4kg, Radix Ginseng 3kg, Fructus Ligustri Lucidi 3kg, Radix Angelicae Sinensis 5kg, Agkistrodon powder 10kg, glasses snake powder 8kg grind into the above powder of 120 orders, with China northern agkistrodon halys ussuriensis poison 2.5kg, basin, the Chinese middle and lower reach of Yangtze River blunt tail agkistrodon halyx pallas venom 2kg, agkistrodon acutus venom 5.5kg, cobra venom 4kg, Ophiophagus hannah (Cantor). 2kg, bungarotoxin 1kg puddle evenly, and fill becomes the 0.3g/ capsules to get finished product.
Embodiment 4
With the toad after the intensive drying slough off 0.5kg, Bufo siccus dried bark 3kg, Ganoderma spore powder 8kg, powder of Radix Puerariae 12kg, Semen Coicis 7kg, Rhizoma Typhonii 3kg, Radix Tripterygii Wilfordii 7kg, Fructus Chaenomelis 3, Radix Notoginseng 6.5kg, Radix Ginseng 7kg, Fructus Ligustri Lucidi 7kg, Radix Angelicae Sinensis 3kg, Agkistrodon powder 10kg, glasses snake powder 8kg grind into the above powder of 120 orders, with China northern agkistrodon halys ussuriensis poison 2kg, basin, the Chinese middle and lower reach of Yangtze River blunt tail agkistrodon halyx pallas venom 2kg, agkistrodon acutus venom 5kg, cobra venom 4kg, Ophiophagus hannah (Cantor). 2.5kg, bungarotoxin 1.5kg puddles evenly, and fill becomes the 0.3g/ capsules to get finished product.
Claims (1)
1. Snake Venom Capsule for the treatment of cancer, by weight, snake venom: Chinese medicine=1: 5;
The parts by weight of described snake venom are:
China northern agkistrodon halys ussuriensis poison 1.5-2.5, basin, the Chinese middle and lower reach of Yangtze River blunt tail agkistrodon halyx pallas venom 1.5-2.5, agkistrodon acutus venom 4-6, cobra venom 2-4, Ophiophagus hannah (Cantor). 1.5-2.5, bungarotoxin 0.5-1.5;
The parts by weight of described Chinese medicine are:
Toad is sloughed off 0.5-1.5, Bufo siccus dried bark 3-5, Ganoderma spore powder 8-12, powder of Radix Puerariae 12-18, Semen Coicis 3-7, Rhizoma Typhonii 3-7, Radix Tripterygii Wilfordii 3-7, Fructus Chaenomelis 3-7, Radix Notoginseng 3-7, Radix Ginseng 3-7, Fructus Ligustri Lucidi 3-7, Radix Angelicae Sinensis 3-7, Agkistrodon powder 10-20, glasses snake powder 8-22.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105054122A CN101961466B (en) | 2010-10-09 | 2010-10-09 | Snake venom capsule for treating cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105054122A CN101961466B (en) | 2010-10-09 | 2010-10-09 | Snake venom capsule for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101961466A CN101961466A (en) | 2011-02-02 |
| CN101961466B true CN101961466B (en) | 2011-11-23 |
Family
ID=43514640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105054122A Active CN101961466B (en) | 2010-10-09 | 2010-10-09 | Snake venom capsule for treating cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101961466B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191268B (en) * | 2013-04-29 | 2014-07-09 | 滨州医学院附属医院 | Traditional Chinese medicinal composition for treating lung cancer |
| CN110755455A (en) * | 2019-11-15 | 2020-02-07 | 何增义 | Composition for promoting wound healing of diabetic complications and preparation method thereof |
-
2010
- 2010-10-09 CN CN2010105054122A patent/CN101961466B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN101961466A (en) | 2011-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104606513A (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine | |
| CN102210820A (en) | Chinese medicinal composition for treating leukemia | |
| CN101926882A (en) | Medicinal composition for treating cancer and preparation methods thereof | |
| CN101926942A (en) | Glucose-lowering health care medicinal tea and preparation method thereof | |
| CN102920868B (en) | Miao medicine for treating pancreatic diseases | |
| CN101961466B (en) | Snake venom capsule for treating cancer | |
| CN100396315C (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
| CN106692548A (en) | Medicine for treating scapulohumeral periarthritis and preparation method thereof | |
| CN106266408A (en) | A kind of use Huangqi Compound medicine repairing nerve damage Therapeutic Method | |
| CN100534488C (en) | Traditional Chinese medicinal powder for treating psoriasis | |
| CN102172369A (en) | Chinese medicine for treating hepatocirrhosis | |
| CN101375965B (en) | Chinese medicine honeyed bolus for treating recurrent psoriasis in progressive stage | |
| CN101028473A (en) | Chinese medicine for treating bed-wetting disease and its production | |
| CN106390060A (en) | Health preserving foot patch and processing technology thereof | |
| CN101658652A (en) | Chinese medicinal preparation for treating chronic appendicitis | |
| CN1228067C (en) | Biochemical medicament of araliaceae plant and its preparation method | |
| CN105362682A (en) | External-use medicine for treating hypomenorrhea | |
| CN104083580A (en) | Traditional Chinese medicine for treating senile dementia | |
| CN101810745B (en) | Plaster for treating hyperplasia of mammary glands | |
| CN101647965A (en) | Internal medicine for treating chronic nephritis | |
| CN105456447A (en) | Folium artemisiae argyi-containing traditional Chinese medicine composition with function of promoting blood circulation to remove stasis and preparation method thereof | |
| CN106344680A (en) | Traditional Chinese medicinal composition with effects of expelling wind and relieving cold-aggravated arthralgia and preparation method thereof | |
| CN101485857B (en) | Chinese medicine for tonifying kidney, invigorating heart and spleen, and strengthening function of human body and preparation method thereof | |
| CN105343705A (en) | Rheumatoid arthritis treatment medicine | |
| CN103768251B (en) | A kind of medicine killed virus in blood cell, improve human antibody's immunizing power |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |